A new cutting-edge blood-based biomarker test developed by researchers at Hong Kong University of Science and Technology can ...
South China University of Technology and affiliated organizations have published data from a study that aimed to assess the ...
Abbvie Inc. and Tentarix Biotherapeutics Inc. have established a multiyear collaboration focused on the discovery and ...
The new director of the U.S. NIH, Monica Bertagnolli, has set out the prospectus for her tenure, saying she intends to apply ...
In what represents its first patenting, San Diego-based Intrigue Health Inc. seeks protection for a diagnostic kit that its ...
In the first month of 2024, BioWorld reported on 252 phase I-III clinical trial updates, marking a 10% decrease from the 281 ...
Clearmind Medicine Inc. has received approval from Israel’s Ministry of Health to initiate a phase I/IIa trial of CMND-100 ...
Zimmer Biomet Holdings Inc.’s Rosa robotics surgical assistant snapped up its fourth application with the U.S. FDA’s 510(k) ...
The U.S. FDA’s December 2023 draft guidance for the use of real-world evidence (RWE) for medical devices drew comment from ...
The U.S. FDA issued an update to a previous advisory to doctors regarding the use of electromyogram endotracheal tubes made by Dublin-based Medtronic plc., but there is still some noise in the ...
Recent Cedilla Therapeutics Inc. patents describe new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer, autoimmune diseases, Cushing syndrome, Alzheimer’s disease, hepatic ...
At the ongoing European Crohn’s and Colitis Organization (ECCO) meeting, researchers from Kangpu Biopharmaceuticals Ltd. presented efficacy data on KPG-818, a lenalidomide analogue, in a mouse model ...